Complete Pathological Response in Stage IV Rectal Carcinoma: Proper Planning and Place is a Key
Introduction: Liver metastasis is frequently encountered in patients with rectal cancer; it can be synchronous or metachronous. Some selected patients can be treated with curative intent using multimodality therapy under the care of a dedicated team in a comprehensive cancer center. However, the treatment is long and tiring for the treating team, the patient, and the relatives. Treatment is difficult to execute in a country like ours with a limited number of cancer centers. We present a patient from a remote village with stage IV disease, who completed all modalities of treatment with a favorable outcome.
Case Presentation: A fifty-five-year-old man from a remote village presented to us with a complaint of per rectal bleeding. He was diagnosed with rectal carcinoma with solitary liver metastases. He received multimodality treatment in the form of chemotherapy, radiotherapy, and surgery. He attained a complete pathological response at both primary and metastatic sites.
Conclusions: Good outcomes can be achieved in selected stage IV rectal cancer. This requires multimodality treatment and a proper plan, preferably in a comprehensive cancer center
Van der Geest LGM, Lam-Boer J, Koopman M, et
al. Nationwide trends in incidence, treatment and
survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis. 2015 Jun;32(5):457–65.
Van der Pool AEM, Damhuis RA, Ijzermans JNM, et
al. Trends in incidence, treatment and survival of
patients with stage IV colorectal cancer: a population-based series. Colorectal Dis Off J Assoc Coloproctology G B Irel. 2012 Jan;14(1):56–61.
Kanas GP, Taylor A, Primrose JN, et al. Survival after
liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin
Epidemiol. 2012;4:283–301. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999 Sep;230(3):309–18; discussion 318–21.
Adam R, de Gramont A, Figueras J, et al. Managing
synchronous liver metastases from colorectal cancer:
a multidisciplinary international consensus. Cancer
Treat Rev. 2015 Nov;41(9):729–41.
Weledji EP. Centralization of Liver Cancer Surgery
and Impact on Multidisciplinary Teams Working on
Stage IV Colorectal Cancer. Oncol Rev. 2017 Jun 14;11(2):331.
Oxenberg J, Papenfuss W, Esemuede I, et al.
Multidisciplinary cancer conferences for gastrointestinal malignancies result in measureable
treatment changes: a prospective study of 149 consecutive patients. Ann Surg Oncol. 2015 May;22(5):1533–9.
Sauer R, Liersch T, Merkel S, et al. Preoperative
versus postoperative chemoradiotherapy for locally
advanced rectal cancer: results of the German CAO/
ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol Off J Am Soc Clin Oncol. 2012 Jun 1;30(16):1926–33.
Van Cutsem E, Cervantes A, Adam R, et al. ESMO
consensus guidelines for the management of patients
with metastatic colorectal cancer. Ann Oncol Off J
Eur Soc Med Oncol. 2016 Aug;27(8):1386–422.
Sabanathan D, Eslick GD, Shannon J. Use of Neoadjuvant Chemotherapy Plus Molecular Targeted
Therapy in Colorectal Liver Metastases: A Systematic
Review and Meta-analysis. Clin Colorectal Cancer. 2016 Dec;15(4):e141–7.
Krell RW, D’Angelica MI. Treatment sequencing for
simultaneous colorectal liver metastases. J Surg Oncol. 2019 Apr;119(5):583-593.
Maas M, Nelemans PJ, Valentini V, et al. Long-term
outcome in patients with a pathological complete
response after chemoradiation for rectal cancer: a
pooled analysis of individual patient data. Lancet
Oncol. 2010 Sep;11(9):835–44.
Article MetricsAbstract view : 119 times
PDF - 39 times
- There are currently no refbacks.
Copyright (c) 2022 Indonesian Journal of Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.